Howard Hughes Medical Institute’s Salesforce CRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.35M Buy
12,612
+12,407
+6,052% +$2.57M 0.57% 26
2025
Q4
$54.3K Sell
205
-1
-0.5% -$249 0.03% 39
2025
Q3
$48.8K Hold
206
0.03% 37
2025
Q2
$56.2K Buy
+206
New +$55.1K 0.02% 33
2017
Q3
Sell
-4,361
Closed -$378K 54
2017
Q2
$378K Buy
+4,361
New +$380K 0.07% 105
2017
Q1
Sell
-4,982
Closed -$341K 153
2016
Q4
$341K Buy
+4,982
New +$362K 0.08% 109

Other funds holding CRM

Howard Hughes Medical Institute's CRM Position: Q1 2026 in Review

Howard Hughes Medical Institute increased its Salesforce (CRM) stake by 6,052% in Q1 2026, buying an estimated $2.57M and bringing the position to 12,612 shares worth $2.35M. The position accounts for 0.57% of the portfolio, ranked #26.

Howard Hughes Medical Institute first reported a position in CRM in Q4 2016 and has held it in 6 quarters since. 2,672 funds tracked by Wall St. Rank hold CRM as of Q1 2026.

  • Howard Hughes Medical Institute held 12,612 shares of Salesforce worth $2.35M as of Q1 2026.
  • Howard Hughes Medical Institute bought 12,407 Salesforce shares in Q1 2026, an estimated $2.57M.
  • Salesforce made up 0.57% of Howard Hughes Medical Institute's portfolio in Q1 2026, its #26 holding.
  • Howard Hughes Medical Institute first reported a position in Salesforce in Q4 2016 and has held it in 6 quarters since.
  • 2,672 funds tracked by Wall St. Rank held Salesforce as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.